Comments on “Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials : a multicenter retrospective study” / E.G. Favalli, F. Conti, F. Atzeni, C. Selmi, S. D'Angelo, R. Caporali, F. Iannone. - In: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. - ISSN 0190-9622. - 79:6(2018), pp. e119-e120.

Comments on “Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials : a multicenter retrospective study”

E.G. Favalli
;
C. Selmi;R. Caporali;
2018

Humans; Retrospective Studies; Psoriasis; Thalidomide
Settore MED/16 - Reumatologia
2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
main.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 92.55 kB
Formato Adobe PDF
92.55 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/663493
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 3
social impact